Asia Pacific Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical, Medical Devices, Research and Development, and Others)
Market Introduction
Biopharmaceutical tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps. These offer exceptional thermal, mechanical, and chemical properties used in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific biopharmaceutical tubing market is expected to reach US$ 903.19 million by 2028 from US$ 487.50 million in 2021; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. The growth of the market is attributed to key factors such as increasing elderly population in world and proliferation of healthcare sector in developing economies. However, stringent regulatory framework by government for biopharmaceutical applications is expected to restrict the market growth during the forecast period.
Popularity of minimally invasive surgical procedures has increased in the recent years owing to the benefits such as tiny incisions, faster recovery of patients, and less discomfort caused to the patients. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted the demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Further, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing. The healthcare sectors in Asia Pacific countries as well as other developing economies is projected to expand rapidly in the near future, and the projected growth can be ascribed to changes in customer demand, increase in awareness about healthcare services, and continuity of aging population. Thus, growing prevalence of chronic diseases is compelling people to seek medical assistance, which, in turn is increasing the demand for catheters and biopharmaceutical tubing in the healthcare sector. Further, greater government spending on healthcare facilities and increased consumer purchasing power are also likely to contribute to the growth of the healthcare sector, as well as the biopharmaceutical tubing market.
Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. Increasing usage in a wide range of applications such as drug delivery, catheter & cannulas, and bulk disposable tubing has increased the demand for the biopharmaceutical tubing market. However, due to the impact of pandemic, the medical device industry has experienced both ups and downs and witnessed increased demand for critical pieces of equipment such as ventilators and respiratory devices. While the COVID-19 has caused unprecedented disruption, it has also created opportunities for the region's pharmaceutical and medical device sectors. Many companies have also extended their operations in the region to overcome supply chain hindrance. Hence, COVID-19 pandemic has a positive influence on Asia Pacific biopharmaceutical tubing market growth.
Key Market Segments
Based on type, the Asia Pacific biopharmaceutical tubing market is segmented into plastic, metal, and silicone. The silicone segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Based on application, the Asia Pacific biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Asia Pacific biopharmaceutical tubing market are the Organization for Economic Co-operation and Development (OECD), Indian Brand Equity Fund (IBEF) and Centers for Disease Control and Prevention (CDC).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Asia Pacific biopharmaceutical tubing market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Asia Pacific biopharmaceutical tubing market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific biopharmaceutical tubing market.
ASIA PACIFIC BIOPHARMACEUTICAL TUBING MARKET SEGMENTATION
By Type
- Silicone
- Plastic
- Metal
By Application
- Pharmaceutical
- Medical Devices
- Research and Development
- Others
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Company Profiles
- W. L. Gore and Associates, Inc.
- Saint-Gobain Sekurit
- Freudenberg Group
- RAUMEDIC AG
- TEKNI-PLEX
- NewAge Industries, Inc
- Optinova
- Zeus Industrial Products, Inc.
- NORDSON CORPORATION
- DuPont de Nemours, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Biopharmaceutical Tubing Market – By Type
1.3.2 Asia Pacific Biopharmaceutical Tubing Market – By Application
1.3.3 Asia Pacific Biopharmaceutical Tubing market – By Country
2. Biopharmaceutical Tubing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Biopharmaceutical Tubing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinions
5. Biopharmaceutical Tubing Market – Key Market Dynamics
5.1 Drivers
5.1.1 Increasing Elderly Population in World
5.1.2 Rising Demand for Minimally Invasive Procedures
5.2 Market Restraints
5.2.1 Stringent Regulatory Framework
5.3 Market Opportunities
5.3.1 Proliferation of Healthcare Sector and Rise in Prevalence of Chronic Diseases in Developing Countries
5.4 Future Trends
5.4.1 Use of Platinum-Cured Silicone as Material of Choice for Biopharmaceutical Tubing
5.5 Impact Analysis
6. Biopharmaceutical Tubing Market – Asia Pacific Analysis
6.1 Asia Pacific Biopharmaceutical Tubing Market Revenue Forecast and Analysis
7. Biopharmaceutical Tubing Market Analysis – By Type
7.1 Overview
7.2 Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
7.3 Plastic
7.3.1 Overview
7.3.2 Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metal
7.4.1 Overview
7.4.2 Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Silicone
7.5.1 Overview
7.5.2 Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8. Biopharmaceutical Tubing Market Analysis – By Application
8.1 Overview
8.2 Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
8.3 Pharmaceutical
8.3.1 Overview
8.3.2 Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Medical Devices
8.4.1 Overview
8.4.2 Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Research and Development
8.5.1 Overview
8.5.2 Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
9. Biopharmaceutical Tubing Market – Asia Pacific Analysis
9.1 Asia Pacific: Biopharmaceutical Tubing Market
9.1.1 Overview
9.1.2 Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
9.1.2.1 Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 Japan: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.1.3 Japan: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.2 China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 China: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.2.3 China: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.3 India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 India: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.3.3 India: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.4 South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.1 South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2 South Korea: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.4.3 South Korea: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.5 Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.1 Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.2 Australia: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.5.3 Australia: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
9.1.2.6 Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.1 Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.2 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type, 2019–2028 (USD Million)
9.1.2.6.3 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application, 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on Asia Pacific Biopharmaceutical Tubing Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Biopharmaceutical Tubing Market – Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 W. L. Gore and Associates, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Saint-Gobain Sekurit
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Freudenberg Group
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 RAUMEDIC AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 TEKNI-PLEX
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NewAge Industries, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Optinova
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Zeus Industrial Products, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NORDSON CORPORATION
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 DuPont de Nemours, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Japan: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Japan: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. India: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. India: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. South Korea: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. South Korea: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Australia: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Australia: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Biopharmaceutical Tubing Market
LIST OF FIGURES
Figure 1. Biopharmaceutical Tubing Market Segmentation
Figure 2. Biopharmaceutical Tubing Market Segmentation, By Country
Figure 3. Biopharmaceutical Tubing Market Overview
Figure 4. Silicone Segment Held Largest Share of Biopharmaceutical Tubing Market
Figure 5. Asia Pacific Biopharmaceutical Tubing Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 7. Asia Pacific Biopharmaceutical Tubing Market – Revenue Forecast and Analysis – 2020- 2028
Figure 8. Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
Figure 9. Plastic: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Metal: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Silicone: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
Figure 13. Pharmaceutical: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Medical Devices: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Research and Development: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Asia Pacific: Biopharmaceutical Tubing Market, by Key Country – Revenue (2021) (USD Million)
Figure 18. Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 19. Japan: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 20. China: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 21. India: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 22. South Korea: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 23. Australia: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Rest of Asia Pacific: Biopharmaceutical Tubing Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
- W. L. Gore and Associates, Inc.
- Saint-Gobain Sekurit
- Freudenberg Group
- RAUMEDIC AG
- TEKNI-PLEX
- NewAge Industries, Inc
- Optinova
- Zeus Industrial Products, Inc.
- NORDSON CORPORATION
- DuPont de Nemours, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific biopharmaceutical tubing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific biopharmaceutical tubing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.